Tetra Natural Health Signs a Supply Agreement with Namaste Technologies for the Marketing and Distribution of Rx Princeps™, its Premium Medicinal Cannabis Product
Momentum Public Relations
Press Release: May 17
Tetra Natural Health a division of Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF) and – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSX-V:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that the Company has signed a Supply Agreement ( the “Supply Agreement”) for the sale and distribution of Rx Princeps™ the medicinal cannabis brand of Tetra Natural Health, a division of Tetra Bio-Pharma (“Tetra Bio-Pharma”)(TSX-V:TBP) (OTCQB:TBPMF), whereby Namaste will purchase Rx Princeps™ from Tetra Natural Health which will be sold through Namaste’s wholly owned subsidiary Access to Cannabis for Medical Purposes (“ACMPR”) medical cannabis “sales-only” facility, Cannmart Inc. (“Cannmart”). The agreement also includes the sales of Tetra Natural Health’s specially designed inhalation device, air filters and its Munchies B Gone gum.
Guy Chamberland, Interim CEO and CSO of Tetra Bio-Pharma comments “We are thrilled to have signed this partnership deal with Namaste who operates as an E-Commerce Medicinal Cannabis distributor with 32 sites in 20 countries, providing substantial exposure for Tetra Natural Health’s Rx Princeps™ brand of premium medicinal cannabis. We believe this is the making of a solid partnership with Tetra Natural Health’s ability to produce a quality product combined with Namaste’s far reaching sales and distribution network”.
Sean Dollinger, President and CEO of Namaste comments; “We are very proud to be bringing on a strong supply partner like Tetra Bio-Pharma. Rx Princeps™ is a unique pharma-based product that we feel will be very valuable for our patients. We have a unique opportunity to develop an exciting platform that will cater specifically to a patient’s needs. We plan on providing a single source for all things cannabis and Cannmart and NamasteMD are key components of that strategy along with securing the highest quality cannabis for our patients. We’d like to take the opportunity to thank Tetra Bio-Pharma management team for their support and look forward to a growing future together.”
Rx Princeps™ is a unique blend of 3 strains of medical cannabis. Its production has been standardized in order to ensure a lot-to-lot consistent composition in its active ingredients (THC and CBD).
About Tetra Bio Pharma
Tetra Bio-Pharma (TSX-V:TBP) (OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a clinical program aimed at bringing novel drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries that are engaged in the development of Bio Pharmaceuticals and Natural Health Products containing cannabis and other medicinal plant-based elements. Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.
About Namaste Technologies Inc.
Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.
Source: Tetra Bio-Pharma
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a license for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
More information at: www.tetrabiopharma.com
For further information, please contact:
Tetra Bio-Pharma Inc.
Robert (Bob) Béchard
Vice President Finance and Business Development
bob@tetrabiopharma.comC 514 817-2514
For media information, please contact:
Daniel Granger
Daniel.granger@acjcommunication.com
ACJ Communication
O: 1 514 840 7990
M: 1 514 232 1556
For more information from Namaste Technologies, please contact:
Sean Dollinger, President and Chief Executive Officer
Namaste Technologies Inc.
Direct: +1 (786) 389 9771
Email: info@namastetechnologies.com
- Published in Tetra Bio Pharma
ProSmart Announces Launch of Proprietary Engagement Technology that Amplifies Reach Across Social Media
Momentum Public Relations
Press Release: May 14 2018
ProSmart Enterprises Inc. (TSXV:PROS) (“ProSmart” or the “Company”), parent company of SportgoTM, a global online network connecting sports fans, teams and brands, is pleased to announce the official launch of its proprietary engagement technology (the “Marketplace Engine”). The technology, which is able to amplify the reach of content across all major social media platforms, will help the Company attract more users and grow sponsorship revenues for its SportgoTM platform. The Marketplace Engine has been tested by select ProSmart partners, such as the Vancouver Canucks and Red Bull, and is proving to be a major source of interest to over 120 prospective new partners, including pro teams, leagues, brands and other organizations.
The Marketplace Engine provides the following benefits to ProSmart’s SportgoTM online network and partners:
- Amplifies Social Media Reach: Allows users to share content within SportgoTM and across all other major social platforms including Facebook, Instagram, Twitter, Pinterest and others.
- Social Media Insights: Provides unique analytics on the content, influencers and platforms that most effectively attract specific types of fans and users. This includes insights into how content sharing and other marketing strategies can grow users, revenue and, ultimately, sports.
- High-Engagement Marketing: Enables SportgoTM partners to run digital marketing strategies, ranging from targeted content distribution, delivery of branded promotions, contests and prizing.
- The Online Network of Choice for Sports Celebrities: Enables high profile SportgoTMinfluencers (“Influencers”), such as Wendel Clark, Hayley Wickenheiser and Craig Forrest to significantly expand their reach.
The Marketplace Engine has been tested successfully with ProSmart on a wide range of promotional campaigns with groups such as the Vancouver Canucks, BC Hockey, Red Bull and the Wickenheiser World Female Hockey Festival.
Campaigns to date have included promotions and contests that engaged participants via email and social media posts. In addition, the Marketplace Engine was used to support several Red Bull events in 2018, including Crashed Ice in Edmonton and the Canada-wide Name Our Challenge contest.
Use of the Marketplace Engine, with support from ProSmart’s digital marketing team, was instrumental in driving a high level of fan awareness, content distribution and event participation. Original posts on social media were designed with incentives for recipients to share across all major social media platforms and the impact of this sharing was then analyzed and found to increase overall reach above traditional social media sharing by 70%.
Says Alan Schuler, CEO and Co-founder of ProSmart, “The Marketplace Engine gives us a strong, competitive advantage in the $1.3 trillion global sports market and we are not aware of any social media or sport-related, online entity that has this technology. Our current partners have been delighted with results to date and they are keen to launch additional fan engagement programs. With the Marketplace Engine now available to all partners, we are looking forward to delivering on our business goal of becoming the number one destination for sports enthusiasts and the partner of choice for teams, brands and corporations.”
On behalf of ProSmart Enterprises Inc.
Alan Schuler
Co-Founder & Chief Executive Officer
About ProSmart Enterprises Inc.
ProSmart Enterprises Inc. (TSX-V:PROS) is the parent company of SportgoTM, a global online network connecting sports fans, teams and brands and is an emerging leader in sports content marketing through online tools and mobile apps. SportgoTM works with over 1,500 governing bodies in more than 100 countries and provides unprecedented access to the $1.3 trillion sports market through its proprietary Marketplace Engine. SportgoTM is also the first-and-only online network to provide educational content created exclusively by hall-of-fame and professional athletes, which has been a key driver in user growth.
For more information on ProSmart and SportgoTM, please visit the following links:
ProSmart Enterprises Inc. — http://prosmartinc.com
SportgoTM — https://www.sportgo.com/
Investors can stay connected with ProSmart by following on:
LinkedIn — https://www.linkedin.com/company/prosmartsports/
CrunchBase — https://www.crunchbase.com/organization/prosmart-sports-development-inc
AngelList — https://angel.co/prosmart-sports-development
For further information please contact:
t: 1-844-927-6278
e: investment@prosmartsports.com
The shares of ProSmart Enterprises Inc. trade publicly on the TSX Venture Exchange under the symbol TSXV:PROS.
“Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.”
Forward-looking Statements: Certain statements in this press release are “forward-looking statements” which reflect the Company’s current expectations and projections about future events and financial trends that it believes might affect its financial condition, results of operations, business strategy and financial needs. In some cases, these forward-looking statements can be identified by words or phrases such as “may”, “might”, “will”, “expect”, “anticipate”, “estimate”, “intend”, “plan”, “indicate”, “seek”, “believe”, “estimates”, “predicts” or “likely”, or the negative of these terms, or other similar expressions intended to identify forward-looking statements. Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including without limitation, those risks and uncertainties discussed elsewhere on the website at www.prosmartinc.com and in the Company’s filings on SEDAR. Investors should not place undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date hereof and is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.
To view the original release, please click here
Source: ProSmart Enterprises Inc. (TSX Venture:PROS, FWB:1R6)
To follow ProSmart Enterprises Inc. on your favorite social media platform or financial websites, please click on the icons below.
- Published in Prosmart Enterprises
Arctic Star Announces 100% Increase to Land Position, Timantti Project, Finland
Momentum Public Relations
Press Release: May 10 2018
Arctic Star Exploration Corp. (TSXV: ADD) (OTCQB: ASDZF) (FSE: 82A1) (“Arctic Star” or the “Company”) is pleased to announce that it has increased its land position by 100% on the Timantti Diamond Project in Finland (the “Project”). The Project now comprises a total of 193,700 Ha under an Exploration Reservation, representing a district scale land package that is 100% owned with no underlying royalties.
Highlights:
- The Timantti Diamond Project has increased by 98,000 Ha, for a total land package of 193,700 Ha.
- The new Exploration Reservation package extends the pre-existing land package to the south where previous work has discovered at least one kimberlite body.
- The new Exploration Reservation was acquired directly from the Finish Mining Authority at an approximate acquisition cost of $3,750 CDN plus associated legal costs.
- The Company has applied for and anticipates it will receive an Exploration Permit in short order for the new ground to thus begin exploration activity this summer.
+1 (604) 218-8772
- Published in Arctic Star Exploration
Pacton Gold Closes $5.5 Million Private Placement
Momentum Public Relations
Press Release: May 9 2018
Pacton Gold Inc. (TSXV: PAC, OTC: PACXF) (the “Company” or “Pacton“) is pleased to announce that it has closed its previously announced brokered private placement for gross proceeds of $5,550,500 (the “Offering“). Sprott Capital Partners acted as lead agent, on behalf of a syndicate of agents including Red Cloud Klondike Strike Inc. (collectively, the “Agents“).
Under the Offering, the Company issued 24,132,609 units at $0.23 per unit, each unit consisting of one common share of the Company (a “Common Share“) and one transferable common share purchase warrant (a “Warrant“) (collectively, a “Unit“). Each Warrant will entitle the holder to acquire one Common Share for a period of three years from the date of issue at a price of $0.35.
In connection with the Offering, the Agents received a cash fee in an amount equal to 6.0% of the aggregate gross proceeds of the Offering and common share purchase warrants (the “Broker Warrants“) entitling the Agents to subscribe for that number of common shares equal to 6.0% of the aggregate number of Units placed in the Offering. Subject to regulatory approval, each Broker Warrant will be exercisable to acquire one Common share at a price equal to $0.35 for a period of three years after the closing date.
The net proceeds from the Offering will be used for exploration work to be conducted on the Company’s properties in Canada and Australia and for general working capital. All of the securities sold pursuant to the Offering will be subject to a four month hold period which will expire four months and one day from the date of issue in accordance with applicable securities laws. The Offering is subject to final acceptance of the TSX Venture Exchange.
Early Warning Dislcosure of Eric Sprott: Eric Sprott, through his holding company, 2176423 Ontario Ltd., acquired 8,695,700 Units under the Offering for total consideration of approximately $2 million. The 8,695,700 Units, represent approximately 10.1% of the outstanding Common Shares on a non-diluted basis and 18.4% on a partially diluted basis assuming the exercise of the Warrants. Prior to this purchase, Mr. Sprott did not directly or indirectly own any securities of the Company. The Units were acquired for investment purposes. Mr. Sprott has a long-term view of the investment and may acquire additional securities either on the open market or through private acquisitions or sell the securities either on the open market or through private dispositions in the future depending on market conditions, reformulation of plans and/or other relevant factors. A copy of 2176423 Ontario Ltd.’s early warning report will appear with the Company’s documents on SEDAR at www.sedar.com and may also be obtained by contacting Mr. Sprott at (416) 362-7172 (200 Bay Street, Suite 2600, Royal Bank Plaza, South Tower, Toronto, Ontario M5J 2J1).
ON BEHALF OF THE BOARD OF DIRECTORS,
Alec Pismiris
Interim President & CEO
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act“) or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.
This news release includes certain forward-looking statements concerning the use of proceeds of the Offering, the future performance of our business, its operations and its financial performance and condition, as well as management’s objectives, strategies, beliefs and intentions. Forward-looking statements are frequently identified by such words as “may”, “will”, “plan”, “expect”, “anticipate”, “estimate”, “intend” and similar words referring to future events and results. Forward-looking statements are based on the current opinions and expectations of management. All forward-looking information is inherently uncertain and subject to a variety of assumptions, risks and uncertainties, including the speculative nature of mineral exploration and development, fluctuating commodity prices, competitive risks and the availability of financing, as described in more detail in our recent securities filings available at www.sedar.com. Actual events or results may differ materially from those projected in the forward-looking statements and we caution against placing undue reliance thereon. We assume no obligation to revise or update these forward-looking statements except as required by applicable law.
SOURCE Pacton Gold Inc.
View original content: http://www.newswire.ca/en/releases/archive/May2018/09/c5600.html
Contact:
please contact 1-(855)-584-0258 or dom@pactongold.com.
- Published in Pacton Gold Inc.
Dr. Guy Chamberland returns to “Stock Day” Podcast with Everett Jolly to discuss Tetra-Biopharma
Momentum Public Relations
Press Release: May 9 2018
Dr. Guy Chamberland, Co-Founder, Chief Scientific Officer and Interim-CEO of Tetra-Biopharma Inc. (OTCQB:TBPMF) (TSX-V:TBP) (“the Company”) joined Everett Jolly on Uptick Newswire’s “Stock Day” podcast to provide an update to investors and listeners on some recent company news.
In the interview, Dr. Chamberland described Tetra-Biopharma as a unique and small biopharma that is developing prescription cannabis products through the FDA and Health Canada’s regular drug channels. Currently, one of their products is in phase III clinical trials and is on track to be submitted to regulatory authorities. Chamberland mentions that their hope is to get these products in the hands of consumers as soon as possible. The FDA recently granted the company’s product orphan drug status, which is an FDA designation that allocates special status to drugs and/or biologics being designed for the diagnosis, prevention, or treatment of rare medical conditions. Tetra-Biopharma is proud of this achievement, as orphan drug status can add more scientific credibility to their development process and this designation will help them roll out their products sooner. “This draws attention to our clear focus of bringing drugs to unmet medical conditions, including chronic pain,” says Dr. Chamberland. Updates on their lead compounds are set to be released within the next quarter.
While the company has been successful on the drug development side of the business, they have also signed two commercial deals for the Israeli and Portuguese markets. These partnerships will enable Tetra Bio-Pharma to collect upfront payments, milestone payments, and generate a share of the profits in the sales of PPP001. Tetra is active in discussions with companies from around the world interested in commercializing their various products. Once clinical trials conclude, and both the FDA and Health Canada clear the product for distribution, the company hopes to shift focus onto other global markets, including the European and Latin American Markets. Canada is still in the process of legalizing cannabis, and once that happens there will be a better platform for the company to promote the success of their evidence-based products.
Dr. Chamberland is confident in the direction the company is headed with regards to the success of their clinical development, financial position, and continued support of their investors. They are hoping to release some news in a few weeks detailing the benefits their products will bring to cancer and chronic pain patients.
To hear more about Tetra-Biopharma’s product line, their efforts to combat the opioid crisis, and more updates on their international expansion, listen to the full interview at the link below.
About Tetra Bio-Pharma
For more information, visit http://tetrabiopharma.com/
Tetra Bio-Pharma (TSX-V:TBP) (OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a clinical program aimed at bringing novel drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries that are engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.
Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio-pharma industry by regulators, physicians and insurance companies.
Safe Harbor Statement
Certain statements contained herein are “forward-looking statements,” (as defined in the Private Securities Litigation Reform Act of 1995). Tetra Bio-Pharma cautions that statements and assumptions made in this news release constitute forward-looking statements; the company makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, and other estimates made by management. Actual results could differ from current projections or implied results. Premier Biomedical, Inc. undertakes no obligation to revise these statements following the date of this news release.
About Uptick Newswire
Uptick Newswire is a private company reaching out to the masses keeping investors and shareholders up to date on company news and bringing transparency to the undervalued, undersold, micro-cap stocks of the market and is the sole producer of the Uptick Network “Stock Day” Podcast. The Uptick Network “Stock Day” Podcast is an extension of Uptick Newswire and has recently launched the Video Interview Studio located in Phoenix, Arizona.
Investors Hangout is a proud sponsor of Uptick Newswire’s “Stock Day” Podcast.
Contact Information
Dr. Guy Chamberland
Co-Founder, CEO, CSO
Tetra Bio-Pharma Inc.
1 (833) 977-7575
investors@tetrabiopharma.com
- Published in Tetra Bio Pharma
Auxico Announces Memorandum of Understanding With the Department of Bolivar, Colombia, to Produce Gold
Momentum Public Relations
Press Release: May 8 2018
Auxico Resources Canada Inc. (CSE:AUAG) is pleased to announce that it has signed a Memorandum of Understanding (“MOU”) with the government of the Department of Bolivar to produce gold in this area of Colombia.
Under the terms of the MOU, both parties agree to work together to set up gold production operations in Bolivar, which will be managed by Auxico. For its part, the Bolivar government agrees to contribute the following:
- Property on which the gold production will take place;
- Physical security of the gold production operations;
- Help with the permitting process, including specifically any required environmental permits; and
- Liaison with local miners who will supply ore to the Auxico gold production operations.
For its part, Auxico agrees to contribute the following:
- Environmentally friendly technology that will not rely upon mercury or arsenic for gold production;
- Financing and construction of gold producing operations in Bolivar; and
- Management of the export and sale of gold and/or gold concentrates.
At present, there are two issues of importance to the Government of Bolivar that Auxico will address in this partnership. First, a lot of the current gold production is unlicensed and outside of any regulatory framework. Auxico does not intend to mine gold in Bolivar. Rather, it intends to form partnerships with local gold miners who will bring their ore to Auxico’s facilities to be processed. In this way, the Government of Bolivar, through the operations of Auxico, will set up a legal and regulated framework for gold production in this Department of Colombia.
Second, the current unlicensed gold production in Bolivar is often occurring with the use of mercury, which is having a significant negative impact on the environment. By professionalizing the production of gold, and by eliminating the use of mercury in gold production, as outlined in the 2013 United Nations Minamata Convention on Mercury, Auxico will be conducting its operations in an environmentally responsible manner.
Auxico and the Government of Bolivar agree to work together in partnership in this regard and to share the profits of Auxico’s gold production operations in Bolivar, with 75% of net profits going to Auxico and 25% going to the Government of Bolivar.
Both parties agree to negotiate and conclude definitive agreements as quickly as possible.
Mark Billings, President of Auxico commented, “Auxico is pleased to move forward with the Government of Bolivar to produce gold in this area of Colombia. Our team recently met with the Governor of Bolivar, Dumek Turbay, and other government officials in Cartagena, the capital of the Department of Bolivar. We were pleased with the amount of support this concept has. The board and management of Auxico are eager to work with our colleagues in Bolivar to set up gold operations that will not have a negative impact on the environment and that will provide benefits to our stakeholders.
About the Department of Bolivar, Colombia
The Department of Bolivar is located in the northwestern part of Colombia and resembles a tongue that extends from the Caribbean Sea in the northeast section, to the jungles of Carare on the dividing line with the Department of Antioquia. The capital of the department is Cartagena, which is the first city in the Americas to be colonized by the Spanish.
About Auxico Resources Canada Inc.
Auxico Resources Canada Inc. (“Auxico”) in a Canadian company that was founded in 2014 and based in Montreal. Auxico is engaged in the acquisition, exploration and development of mineral properties in Colombia and Mexico.
ON BEHALF OF THE BOARD OF DIRECTORS
Mark Billings
President, Auxico Resources Canada Inc.
mb@auxicoresources.com
Cell: +1 514 296 1641
- Published in Auxico Resources
ProSmart Launches Sportgo Brand and New Technology Platforms
Momentum Public Relations
Press Release: May 7 2018
ProSmart Enterprises Inc. (TSXV:PROS) (“ProSmart” or the “Company”), is pleased to announce the two-phase launch of SportgoTM (www.sportgo.com) – the first globally accessible digital platform designed for sports fans, teams and brands. With phase one now live, SportgoTMcombines ProSmart’s online network with a comprehensive suite of tools and exclusive content, offering:
- Learning – with an industry-leading sports training and education system.
- Sharing – enabling users to post stories, pictures and videos that resonate with their sports community and invite friends and family members to follow teams and athletes.
- Fan tools – such as accessing the latest game results from over 325,000 sporting events worldwide and accessing exclusive content published by their favorite sports professionals.
- Connectivity – to help users to link up with sports teams and groups or to create their own for their friends to join.
- Management – team and event management tools for youth and community-focused sports.
In addition, professional clubs (like the Vancouver Canucks and other ProSmart partners), as well as influencers, associations, governing bodies, schools, academies, public causes, sports brands and media companies, will be able to:
- Increase fan engagement by publishing their own unique sports articles and educational content.
- Tell their stories and strengthen their brands through their own personalized group pages.
- Grow their followers by sharing photos, videos, updates and events through their timeline and newsfeed.
- Attach their own sponsors to their personalized group page in order to increase revenue.
- Publish, promote and track custom advertising campaigns in order to expand their reach.
Says Alan Schuler, CEO and Co-Founder of ProSmart, “As Facebook connects friends and families and LinkedIn connects business people, Sportgo aims to be the #1 destination for sports enthusiasts. To achieve this, we have integrated the ProSmart online network – which has experienced over 1000% growth in user numbers in the past two years – with proprietary tools, exclusive content and new sharing and connectivity features. The result is an ecosystem of resources that enriches players and fans alike.”
Phase one launched on May 1st, 2018 and is the complete integration and rebranding of ProSmart’s player development system with RosterBot’s full suite of team and league management tools. Coaches and players have access to customizable practice plans, animated drills, and HD skills videos. Managers and parents have access to automated event calendars, instant messaging and payment collection tools. Lastly, leagues have access to powerful and easy-to-use club communication, scheduling and registration systems.
Phase two (Fall, 2018) is the scheduled launch of the full suite of content creation, sharing and fan connectivity tools, as well as a proprietary fan development system and sports marketplace engine. Together, this centralized functionality will greatly enhance the company’s ability to acquire, activate, engage and monetize its community in to the future.
On behalf of ProSmart Enterprises Inc.
Alan Schuler
Co-Founder & Chief Executive Officer
About ProSmart Enterprises Inc.
ProSmart Enterprises Inc. (TSX-V:PROS) is the parent company of Sportgo, a global online network connecting sports fans, teams and brands and is an emerging leader in sports content marketing through online tools and mobile apps. Sportgo works with over 1,500 governing bodies in more than 100 countries and provides unprecedented access to the $1.3 trillion sports market through its proprietary Marketplace Engine. Sportgo is also the first-and-only online network to provide educational content created exclusively by hall-of-fame and professional athletes, which has been a key driver in user growth.
For more information on ProSmart and SportgoTM, please visit the following links:
ProSmart Enterprises Inc. — http://prosmartinc.com
SportgoTM — https://www.sportgo.com/
Investors can stay connected with ProSmart by following us on:
LinkedIn — https://www.linkedin.com/company/prosmartsports/
CrunchBase — https://www.crunchbase.com/organization/prosmart-sports-development-inc
AngelList — https://angel.co/prosmart-sports-development
For further information please contact:
t: 1-844-927-6278
e: investment@prosmartsports.com
The shares of ProSmart Enterprises Inc. trade publicly on the TSX Venture Exchange under the symbol TSXV:PROS.
“Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.”
Forward-looking Statements: Certain statements in this press release are “forward-looking statements” which reflect the Company’s current expectations and projections about future events and financial trends that it believes might affect its financial condition, results of operations, business strategy and financial needs. In some cases, these forward-looking statements can be identified by words or phrases such as “may”, “might”, “will”, “expect”, “anticipate”, “estimate”, “intend”, “plan”, “indicate”, “seek”, “believe”, “estimates”, “predicts” or “likely”, or the negative of these terms, or other similar expressions intended to identify forward-looking statements. Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including without limitation, those risks and uncertainties discussed elsewhere on the website at www.prosmartinc.com and in the Company’s filings on SEDAR. Investors should not place undue reliance on forward looking information. The forward looking information contained herein is made as of the date hereof and is not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.
To view the original release, please click here
Source: ProSmart Enterprises Inc. (TSX Venture:PROS, FWB:1R6)
To follow ProSmart Enterprises Inc. on your favorite social media platform or financial websites, please click on the icons below.
- Published in Prosmart Enterprises
Tetra BioPharma Signs Second Commercialization Deal with Azevedos Industria Farmaceutica, S.A. for the Lead RX product PPP001
Momentum Public Relations
Press Release: May 4 2018
Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF), and Azevedos Indústria Farmacêutica, S.A. announced that they have signed a binding term sheet for the marketing and distribution of PPP001 in Portugal. This binding term sheet will pave the way towards signing a Definitive Distribution Agreement.
Tetra is eligible to receive an upfront payment, milestone payments and will be paid a share of the profits generated by the sales of PPP001 in Portugal. Azevedos will also be responsible for registering the product, as well as all marketing and distribution in Portugal.
“We are honored to partner with Azevedos, a company established in 1775, rich in tradition, and a major player in the Portuguese pharmaceutical market. This Partnership deal provides Tetra with its foray into the European market.” stated Dr. Guy Chamberland M.Sc., Ph.D., Interim CEO and Chief Scientific Officer.
“These partnerships are very important for Azevedos Indústria Farmacêutica and mean that international entities recognize our history, values, work and our technology know-how. Although having a long past, Azevedos is a pharmaceutical company turned to the future and focused on new challenges”, says Thebar Miranda, CEO of Azevedos Indústria Farmaceutica, S.A.
About PPP001
On April 4, 2018, Tetra officially started the Phase 3 trial for PPP001 indicated for terminal stage cancer patients with a goal to improving the quality of life of these patients as well as minimizing their pain. PPP001 is being developed to be the first smokable cannabis product for advanced cancer pain available under prescription.
About Azevedos Indústria Farmacêutica, S.A
Azevedos Group is a two-century Portuguese pharmaceutical brand, whose wide scope of activity ranges from development to distribution, leading manufacturing and exports to more than 60 regulated countries worldwide. Azevedos owns more than 300 MAs for the most relevant therapeutic areas covering all technology forms manufactured at its state of the art plant holding the most recognized certifications.
About Tetra Bio-Pharma: Tetra Bio-Pharma (TSX-V:TBP) (OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra is focusing on three core business pillars: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based products. Tetra Bio-Pharma is currently developing a pipeline of five cannabinoid-based products using different delivery systems such as smokable pellets, oral tablets, eye drops and topical ointments.
More information at: www.tetrabiopharma.com
Source: Tetra Bio-Pharma
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a license for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
For further information, please contact:
Tetra Bio-Pharma Inc.
Dr Guy Chamberland, interim CEO and CSO
guy@tetrabiopharma.com
514-220-9225
Robert (Bob) Bechard, MBA, MSc., BA,
Vice-President Finance and Business Development
bob@tetrabiopharma.com
514-817-2514
For media information, please contact:
Daniel Granger
Daniel.granger@acjcommunication.com
ACJ Communication
O: 1 514-840-7990 M: 1 514-232-1556
- Published in Tetra Bio Pharma
Noble Mineral hires Albert Mining for Project 81 work
Momentum Public Relations
Press Release: May 3 2018
Noble Mineral Exploration Inc. (“Noble” or the “Company”) (TSX-V:NOB, FRANKFURT: NB7, OTC.PK:NLPXF) has commissioned an Artificial Intelligence (AI) Technology Interpretation over the entire Project 81 land package. NOB continues to think “outside the box” to enhance and upgrade the target selection process over this extensively under-explored land package, just north of the Kidd Creek VMS Deposit.
NOB has retained Albert Mining Inc., to use its proprietary Computer Aided Resources Detection Software (CARDS) “Artificial Intelligence Technology” to identify Copper-Zinc and Nickel-Cobalt targets initially in Carnegie and Crawford Townships, but intends to expand the survey to the entire 70,000 hectares Project 81 project, covering 12 townships, depending on this initial interpretation over Carnegie and Crawford Townships. Albert Mining Inc., is a leader in the use of Artificial Intelligence (AI) and advance knowledge-extraction techniques in the mining sector.
Noble Mineral’s Project 81 is located within the Kidd-Munro assemblage of the western Abitibi Subprovince in Ontario, and is one of the largest contiguous, underexplored land packages we have encountered and Albert Mining is pleased to have the opportunity to analysed and interpret the mineral potential of Project 81, using our CARDS Technology. The assemblage is one of the most ultramafic-rich volcanic successions of any age in the world and it hosts the Kidd Creek VMS deposit, an important example of bimodal-mafic (ultramafic) volcanic-associated massive sulphide (VMS) deposits.
By using its CARDS technology, Albert Mining will assist Noble Mineral in identifying targets and possible sites with the same signature as known copper-zinc and nickel-cobalt occurrences. Albert Mining will use its proprietary technology to analyze geophysical, geochemical, and geological data to discover the patterns hidden in the large amount of data that Noble Mineral has compiled over the years. This technology has been successful in assisting in the identification of a number of major mineral discoveries specifically in the Ring of Fire and elsewhere.
Randy S.C. Singh P.Geo (ON), P.Eng (ON) VP- Exploration & Project Development a “qualified person” as such term is defined by National Instrument 43-101 has verified the data disclosed in this news release, and has otherwise reviewed and approved the technical information in this news release on behalf of Noble.
About Albert Mining Inc.:
Albert Mining is a junior mining exploration company using Artificial Intelligence (AI) with an extensive portfolio of gold, copper, and diamond properties in Quebec. Albert Mining also recently acquired all assets from DIAGNOS Inc.’s mining division, including the Computer Aided Resources Detection System (“CARDS”). Albert Mining can count on a multidisciplinary team that includes professionals in geophysics, geology, Artificial Intelligence, and mathematics. The Company’s objective is to develop a new royalty stream by significantly enhancing and participating in the exploration success rate of mining
About Noble Mineral Exploration Inc.:
Noble Mineral Exploration Inc. is a Canadian based junior exploration company which, apart from its shareholdings in MacDonald Mines Exploration Ltd. and its interest in the Wawa-Holdsworth gold exploration property in Wawa, Ontario, has as its flag ship program Project 81, a contiguous land package of approximately ~70,000 hectares covering 12 townships immediately north of the Kidd Creek Mine (celebrating its 51 st year of operation). Project 81 which has seen very limited mineral exploration over the last 50 years and has had a number of historical drill indicated Gold, Copper, Lead-Zinc, Silver and Nickel showings. Noble has confirmed the discovery of a very large, low grade Nickel-Cobalt Deposit in Kingsmill Township in 2012, which is within the project area. The Lucas Gold showing was also drill tested by Noble in 2012 with additional follow up drilling in 2018. Assay results are pending. Additional information can be found on our website at www.noblemineralexploration.com.
Cautionary Statement:
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
The foregoing information may contain forward-looking statements relating to the future performance of Noble Mineral Exploration Inc. Forward-looking statements, specifically those concerning future performance, are subject to certain risks and uncertainties, and actual results may differ materially from the Company’s plans and expectations. These plans, expectations, risks and uncertainties are detailed herein and from time to time in the filings made by the Company with the TSX Venture Exchange and securities regulators. Noble Mineral Exploration Inc. does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events or otherwise.
Contacts:
Noble Mineral Exploration Inc.
H. Vance White, President
Phone: 416-214-2250
Fax: 416-367-1954
Email: info@noblemineralexploration.com
Investor Relations
- Published in Albert Mining